ARCHIVES

Patient Advocates; NBCC Delivers 2.6M Signatures, demands 2.6Billion

This article is from The Cancer Letter archive.

Vol. 23 No. 18 | May 9, 1997

Download PDF Visit The Full Archive

Related Articles

In Brief: GAO Probe Of Cancer Control Program Nears End; Renewal Bill Mark Up Not Before Oct. 22

October 12, 1979

Long-term Follow-up Shows ADH and ALH Tissue Abnormalities Can Carry Similar Risk

January 31, 2014

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

Fragmin Cuts Risk Of VE By 50 Percent In Study

January 31, 2003

Funding Opportunities.

May 31, 2002

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014